Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (251-260 of 280) with videos related to

Pageof 28
Sort By:
Epigenetics|March 21, 2012
DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tractSamson Mani, Katarzyna Szymańska, Cyrille Cuenin, et al.
Virchows Archiv : an International Journal of Pathology|June 25, 2013
A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in BrazilJuliana Giacomazzi, Patricia Koehler-Santos, Edenir Inez Palmero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapyFrances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
Leukemia|February 14, 2020
Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transferMathieu Meunier, Audrey Guttin, Sarah Ancelet, et al.
Plos One|June 18, 2014
Prevalence of the TP53 p.R337H mutation in breast cancer patients in BrazilJuliana Giacomazzi, Marcia S Graudenz, Cynthia A B T Osorio, et al.
NPJ Systems Biology and Applications|July 12, 2025
Author Correction: Systems medicine disease maps: community-driven comprehensive representation of disease mechanismsAlexander Mazein, Marek Ostaszewski, Inna Kuperstein, et al.
Critical Reviews in Toxicology|December 5, 2023
From cultivation to cancer: formation of <i>N</i>-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implicationsStephen B Stanfill, Stephen S Hecht, Andreas C Joerger, et al.
Cell Discovery|March 27, 2024
Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasisAlexandre G Casanova, Gael S Roth, Simone Hausmann, et al.
Hepatitis Research and Treatment|November 25, 2011
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from ColombiaMaria-Cristina Navas, Iris Suarez, Andrea Carreño, et al.
Cell Discovery|January 31, 2024
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasisAlexandre G Casanova, Gael S Roth, Simone Hausmann, et al.
Pageof 28

Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Epigenetics|March 21, 2012
DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tractSamson Mani, Katarzyna Szymańska, Cyrille Cuenin, et al.
Virchows Archiv : an International Journal of Pathology|June 25, 2013
A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in BrazilJuliana Giacomazzi, Patricia Koehler-Santos, Edenir Inez Palmero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapyFrances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
Leukemia|February 14, 2020
Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transferMathieu Meunier, Audrey Guttin, Sarah Ancelet, et al.
Plos One|June 18, 2014
Prevalence of the TP53 p.R337H mutation in breast cancer patients in BrazilJuliana Giacomazzi, Marcia S Graudenz, Cynthia A B T Osorio, et al.
NPJ Systems Biology and Applications|July 12, 2025
Author Correction: Systems medicine disease maps: community-driven comprehensive representation of disease mechanismsAlexander Mazein, Marek Ostaszewski, Inna Kuperstein, et al.
Critical Reviews in Toxicology|December 5, 2023
From cultivation to cancer: formation of <i>N</i>-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implicationsStephen B Stanfill, Stephen S Hecht, Andreas C Joerger, et al.
Cell Discovery|March 27, 2024
Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasisAlexandre G Casanova, Gael S Roth, Simone Hausmann, et al.
Hepatitis Research and Treatment|November 25, 2011
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from ColombiaMaria-Cristina Navas, Iris Suarez, Andrea Carreño, et al.
Cell Discovery|January 31, 2024
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasisAlexandre G Casanova, Gael S Roth, Simone Hausmann, et al.
Pageof 28